Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics.

Journal of psychopharmacology (Oxford, England) - 1 Mar 2012

Munro Janet, Skrobot Olivia, Sanyoura May, Kay Victoria, Susce Margaret T, Glaser Paul E A, de Leon Jose, Blakemore Alexandra I F, Arranz Maria J

Abstract excerpt

People with schizophrenia have an increased risk of metabolic syndrome, with consequent elevated morbidity and mortality, largely due to cardiovascular disease. Metabolic disorders comprise obesity, dyslipidemia and elevated levels of triglycerides, hypertension, and disturbed insulin and glucose metabolism. The elevated risk of metabolic syndrome in individuals suffering from schizophrenia is believed to be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Hypertension

Share to Metabolic Diseases

Share to Receptors, G-Protein-Coupled

Share to Receptors, Peptide

Share to Schizophrenia

Source

Identifiers

PMID: 21693553
DOI: 10.1177/0269881111408965

Genes

RLN3
RXFP3
RXFP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics.PMID 21693553Read ↗

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.Semantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic DrugsSemantic proximity Read ↗

Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic PatientsSemantic proximity Read ↗

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients.Semantic proximity Read ↗

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.Semantic proximity Read ↗

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?Semantic proximity Read ↗

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.Semantic proximity Read ↗

No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.